Skip to main content

Table 2 Change in FEV1 assessments from baseline to week 12

From: Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study

Parameter

Change from baseline (L)

LS mean (95% CI)

Difference between groups (L)

LS mean (95% CI)

pvalue for

non-inferiority

Pre-dose FEV 1

   

   Fluticasone/formoterol

0.196 (0.117, 0.275)

–0.061 (–0.161, 0.040)

0.007

   Fluticasone/salmeterol

0.257 (0.177, 0.336)

  

Post-dose FEV 1

   

   Fluticasone/formoterol

0.464 (0.374, 0.555)

–0.013 (–0.129, 0.103)

0.002

   Fluticasone/salmeterol

0.477 (0.384, 0.569)

  
  1. FEV1, forced expiratory volume in the first second; LS, least-squares mean.